Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | retinoic acid receptor RXR | 0.1525 | 1 | 0.5 |
Brugia malayi | ecdysteroid receptor | 0.0572 | 0 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0572 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0572 | 0 | 0.5 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.1346 | 0.8125 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
T/C (functional) | = 142 | In vivo antitumor activity against P-388 lymphocytic leukemia at the dose of 50 mg/kg | ChEMBL. | 7069710 |
T/C (functional) | = 145 | In vivo antitumor activity against P-388 lymphocytic leukemia at the dose of 100 mg/kg | ChEMBL. | 7069710 |
T/C (functional) | = 178 | In vivo antitumor activity against P-388 lymphocytic leukemia at the dose of 200 mg/kg | ChEMBL. | 7069710 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.